Sequent nails down $26M for aneurysm treatment device; Stroke patients getting too many scans;

> Sequent Medical has nailed down $26 million in Series C venture financing to fund continued development of its WEB aneurysm embolization system. Release

> Molecular Detection has raised $1.5 million in new financing to advance its molecular diagnostics tests for sepsis and gastrointestinal disease. Release

> Stroke patients are getting both CT and MRI scans when they should just be receiving the more accurate second option on its own. And the redundancy is driving up healthcare costs, according to a University of Michigan study. Release

> The FDA will begin to collect medical device information for its Emergency Shortages Data Collections System. Story

And Finally... Diabetes patient Laura Ritchie lost consciousness while her foot was under a hot tap for 6 hours and suffered horrific burns. But she is on the mend thanks to a "spray-on skin." Doctors are now hopeful her wound may one day heal. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.